News Search Results
Apr 30, 2025, 16:05 ET KORE Reports Fourth Quarter and Full Year 2024 Results
including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the potential effects of COVID-19; risks related to the rollout of KORE's business and the timing of expected business milestones; risks relating to the integration of KORE's acquired
More news about: KORE Group Holdings, Inc.
Apr 30, 2025, 11:00 ET SmartTRAK Unveils Addressable Market Projection Report for Skin Substitutes to Help Companies Navigate LCD Policy Changes
The global AWC market reached $16B in 2024, more than doubling in size since before the COVID-19 pandemic. This explosive growth has been largely fueled by the US Skin Substitutes Market, which now accounts for nearly 50% of global AWC spend.
More news about: SmartTRAK
Apr 30, 2025, 09:24 ET Korean Artist Ayoung Kim's Work Displayed on LG Billboard in New York's Times Square Following LG Guggenheim Award Win
artificial intelligence (AI) and 3D game engine. The Delivery Dancer series, featured in the Times Square video, draws inspiration from the COVID-19 pandemic and envisions a futuristic Seoul through the journeys of female delivery riders and their interactions with
More news about: LG Corp.
Apr 30, 2025, 09:00 ET AI Companion Pallie AI Raises $2 Million to Reduce Loneliness and Improve Wellbeing
Gallup report found the rate of loneliness among U.S. adults to be on the rise again at 20% after a temporary downward trend following the COVID-19 pandemic.
More news about: AI Companions, Inc.
Apr 30, 2025, 08:00 ET PriceSmart Announces the Release of its Fiscal Year 2024 Sustainability Report Highlighting Key Achievements on Sustainability
of Member, employee or business information, cost increases from product and service providers, interruption of supply chains, novel coronavirus (COVID-19) related factors and challenges, exposure to product liability claims and product recalls, recoverability of moneys owed to PriceSmart from governments,
More news about: PriceSmart, Inc.
Apr 30, 2025, 08:00 ET Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting
obtain approval from regulatory authorities for our product candidates; our ability to protect our intellectual property; the potential impact of COVID-19; the loss of any executive officers or key personnel. In case one or more of these risks or uncertainties deteriorate, or any assumptions are incorrect,
More news about: Mabwell
Apr 30, 2025, 07:30 ET NAPCO Security Technologies to Announce Fiscal Third Quarter 2025 Results Monday, May 5, 2025
trends, and anticipated product performance. These forward-looking statements include, but are not limited to, statements relating to the impact of COVID-19 pandemic; the growth of recurring service revenue and annual run rate; the introduction of new access control and locking products; the opportunities
More news about: NAPCO Security Technologies, Inc.
Apr 30, 2025, 07:00 ET Recurrent Energy Secures $415 Million Corporate Debt Financing to Accelerate Global IPP Growth
geopolitical tensions and conflicts, including impasses, sanctions and export controls; volatility, uncertainty, delays and disruptions related to the COVID-19 pandemic; supply chain disruptions; governmental support for the deployment of solar power; future available supplies of high-purity silicon; demand
More news about: Canadian Solar Inc.
Apr 30, 2025, 07:00 ET Lanvin Group Demonstrates Strategic Resilience in Challenging Luxury Market, Lays Foundation for Future Growth
growth rate, profitability and market opportunity may not be an indication of its actual results or future results; management of growth; the impact of COVID-19 or similar public health crises on Lanvin Group's business; Lanvin Group's ability to safeguard the value, recognition and reputation of its brands
More news about: LANVIN GROUP
Apr 30, 2025, 06:31 ET Cat Financial Announces First-Quarter 2025 Results
(xv) additional tax expense or exposure; (xvi) changes in accounting guidance; (xvii) catastrophic events, including global pandemics such as the COVID-19 pandemic; and (xviii) other factors described in more detail in Cat Financial's Forms 10-Q, 10-K and other filings with the Securities and Exchange
More news about: Cat Financial
Apr 30, 2025, 06:30 ET Caterpillar Reports First-Quarter 2025 Results
services regulations; (xxv) compliance with environmental laws and regulations; (xxvi) catastrophic events, including global pandemics such as the COVID-19 pandemic; and (xxvii) other factors described in more detail in Caterpillar's Forms 10-Q, 10-K and other filings with the Securities and Exchange
More news about: Caterpillar Inc.
Apr 30, 2025, 03:32 ET Uxin Full Year 2024 Annual Letter to Shareholders
actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: impact of the COVID-19 pandemic, Uxin's goal and strategies; its expansion plans; its future business development, financial condition and results of operations; Uxin's
More news about: Uxin Limited
Apr 30, 2025, 03:30 ET Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2024
actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: impact of the COVID-19 pandemic, Uxin's goal and strategies; its expansion plans; its future business development, financial condition and results of operations; Uxin's
More news about: Uxin Limited
Apr 29, 2025, 16:02 ET Zynex Reports First Quarter 2025 Financial Results
produce our products on time and to our specifications' implementation of our sales strategy including a strong direct sales force, the impact of COVID-19 on the global economy; market conditions; the timing, scope and possibility that the repurchase program may be suspended or discontinued; economic
More news about: Zynex, Inc.
Apr 29, 2025, 13:00 ET Solve M.E., Brain Inflammation Collaborative (BIC), ChronicleBio, Complex Disorders Alliance, and CareEvolution Launch Groundbreaking Partnership to Accelerate Research on ME/CFS, Long Covid, and IACCIs
transformative clinical trials. Solve M.E.'s database is uniquely valuable for containing pre- and post-COVID-19 health information, enabling comparisons between individuals with ME/CFS triggered by COVID-19 and those with other origins. This insight helps researchers better understand how the pandemic has
More news about: Solve M.E.
Apr 29, 2025, 11:50 ET Vectra Bank Colorado Announces Retirement of CEO Bruce Alexander
numerous economic cycles and challenges, including the September 11th attacks, the Great Recession of 2008 and 2010, the COVID-19 pandemic, and the regional banking crisis of 2023. Throughout his career, Bruce has been deeply involved in community service and economic
More news about: Vectra Bank Colorado
Apr 29, 2025, 10:05 ET Active Pharmaceutical Ingredients (API) Market to Amass $359.45 Billion by 2030 at CAGR 5.85% - Grand View Research, Inc.
burdens, thereby boosting R&D in APIs. The COVID-19 pandemic underpinned the active pharmaceutical ingredients market, as leading countries and drug companies produced large quantities of components to meet the demand for the treatment of COVID-19. For instance, the U.S. requested that HCQ be imported
More news about: Grand View Research, Inc.
Apr 29, 2025, 09:00 ET Paranovus Entertainment Technology Limited Regains Compliance with Nasdaq Periodic Financial Reports Filing Rule
technology; economic conditions; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic, the COVID-19 outbreak and its impact on our operations and assumptions underlying or related to any of the foregoing and other risks contained in reports filed
More news about: Paranovus Entertainment Technology Ltd.
Apr 29, 2025, 09:00 ET Cedar's Foods CEO Charles Hanna Named 2025 Ellis Island Medal of Honor Recipient
Lebanon have been life-changing: rebuilding churches, stimulating the local economy through job creation, providing thousands of COVID-19 vaccinations and medications during the pandemic, and funding critical infrastructure in his hometown of Karkha, including electricity, schools, and
More news about: Cedar's Foods
Apr 29, 2025, 09:00 ET 7.2 MW Glor Rd Solar Project in Development by SolarBank in New York
environmental laws and regulations can be expensive; corporate responsibility may adversely impose additional costs; the future impact of any resurgence of COVID-19 on the Company is unknown at this time; the Company has limited insurance coverage; the Company will be reliant on information technology systems
More news about: SolarBank Corporation
Apr 29, 2025, 08:30 ET Taoping Reports Full Year 2024 Financial Results
full year 2024, compared to $38.6 million in 2023, which had benefitted from a surge in growth as we emerged from the COVID-19 shutdowns." "We are encouraged by the significant progress we have made and the growing customer demand for our cloud-based technologies for
More news about: Taoping Inc.
Apr 29, 2025, 08:30 ET Freedom Financial Holdings Announces Earnings for First Quarter of 2025
declines in real estate values, increases in unemployment levels, inflation, recessions and slowdowns in economic growth, including as a result of COVID-19 and the impact of geopolitical conflicts, such as the war between Russia and Ukraine; adverse developments in the
More news about: Freedom Financial Holdings
Apr 29, 2025, 08:00 ET Novavax Appoints Charles Newton to Board of Directors
for its COVID-19 vaccine, in particular with respect to its Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA) for approval of its COVID-19 vaccine, or its other product candidates, including for future COVID-19 variant strain changes, its COVID-19-Influenza-Combination
More news about: Novavax, Inc.
Apr 29, 2025, 07:30 ET Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
strategy during pandemic response: Established a global portfolio of CpG 1018 adjuvant commercial supply agreements supporting the development of COVID-19 vaccines, which generated over $950 million in net product revenue from 2020 to 2022.Disciplined
More news about: Dynavax Technologies
Apr 29, 2025, 07:00 ET CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights
FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. CytoSorb is not yet approved or cleared in the United States. In the U.S. and
More news about: Cytosorbents Corp